EU court releases report on Lupin's appeal against pay-for-delay fine
MLex Summary: Drugmaker Lupin has challenged a European Commission antitrust fine imposed for delaying the entry of a cheaper generic version of blood-pressure drug Perindopril. The EU General Court has published...To view the full article, register now.
Already a subscriber? Click here to view full article